company background image
AZN

AstraZeneca LSE:AZN Stock Report

Last Price

UK£100.32

Market Cap

UK£155.5b

7D

-0.5%

1Y

-10.2%

Updated

29 Nov, 2023

Data

Company Financials +

AZN Stock Overview

AstraZeneca PLC, a biopharmaceutical company, focuses on the discovery, development, manufacture, andcommercialization of prescription medicines.

AZN fundamental analysis
Snowflake Score
Valuation4/6
Future Growth4/6
Past Performance4/6
Financial Health3/6
Dividends4/6

AstraZeneca PLC Competitors

Price History & Performance

Summary of all time highs, changes and price drops for AstraZeneca
Historical stock prices
Current Share PriceUK£100.32
52 Week HighUK£123.92
52 Week LowUK£97.78
Beta0.18
1 Month Change-1.82%
3 Month Change-5.91%
1 Year Change-10.16%
3 Year Change26.40%
5 Year Change65.76%
Change since IPO1,410.84%

Recent News & Updates

AstraZeneca (LON:AZN) Could Easily Take On More Debt

Nov 29
AstraZeneca (LON:AZN) Could Easily Take On More Debt

Recent updates

AstraZeneca (LON:AZN) Could Easily Take On More Debt

Nov 29
AstraZeneca (LON:AZN) Could Easily Take On More Debt

Is There An Opportunity With AstraZeneca PLC's (LON:AZN) 35% Undervaluation?

Sep 11
Is There An Opportunity With AstraZeneca PLC's (LON:AZN) 35% Undervaluation?

Is AstraZeneca (LON:AZN) Using Too Much Debt?

Aug 21
Is AstraZeneca (LON:AZN) Using Too Much Debt?

Shareholder Returns

AZNGB PharmaceuticalsGB Market
7D-0.5%-0.6%-0.5%
1Y-10.2%-6.6%-5.3%

Return vs Industry: AZN underperformed the UK Pharmaceuticals industry which returned -6.6% over the past year.

Return vs Market: AZN underperformed the UK Market which returned -5.3% over the past year.

Price Volatility

Is AZN's price volatile compared to industry and market?
AZN volatility
AZN Average Weekly Movement3.6%
Pharmaceuticals Industry Average Movement6.0%
Market Average Movement5.1%
10% most volatile stocks in GB Market12.0%
10% least volatile stocks in GB Market2.6%

Stable Share Price: AZN is less volatile than 75% of UK stocks over the past 3 months, typically moving +/- 4% a week.

Volatility Over Time: AZN's weekly volatility (4%) has been stable over the past year.

About the Company

FoundedEmployeesCEOWebsite
199283,500Pascal Soriothttps://www.astrazeneca.com

AstraZeneca PLC, a biopharmaceutical company, focuses on the discovery, development, manufacture, andcommercialization of prescription medicines. The company’s marketed products include Calquence, Enhertu, Faslodex, Imfinzi, Iressa, Koselugo, Lumoxiti, Lynparza, Orpathys, Tagrisso, and Zoladex for oncology; Andexxa/Ondexxya, Atacand, Atacand HCT, Atacand Plus, Brilinta/Brilique, Bydureon/Byetta, BCise, Byetta, Crestor, Evrenzo, Farxiga/Forxiga, Komboglyze/Kombiglyze XR, Lokelma, Onglyza, Qtern, Xigduo/Xigduo, and Zestril XR for cardiovascular, renal, and metabolism diseases; Accolate, Accoleit, Vanticon, Bevespi Aerosphere, Breztri Aerosphere, Bricanyl Respules and Turbuhaler, Daliresp/Daxas, Duaklir Genuair, Fasenra, Pulmicort, Rhinocort, Saphnelo, Symbicort, and Tezspire for respiratory and immunology; and Kanuma, Soliris, Strensiq, and Ultomiris for rare diseases. Its marketed products also comprise Synagis for respiratory syncytial virus; Fluenz Tetra/FluMist Quadrivalent for Influenza; and Vaxzevria and Evusheld for covid-19.

AstraZeneca PLC Fundamentals Summary

How do AstraZeneca's earnings and revenue compare to its market cap?
AZN fundamental statistics
Market CapUK£155.49b
Earnings (TTM)UK£4.65b
Revenue (TTM)UK£35.46b

33.5x

P/E Ratio

4.4x

P/S Ratio

Earnings & Revenue

Key profitability statistics from the latest earnings report
AZN income statement (TTM)
RevenueUS$44.99b
Cost of RevenueUS$4.87b
Gross ProfitUS$40.12b
Other ExpensesUS$34.23b
EarningsUS$5.90b

Last Reported Earnings

Sep 30, 2023

Next Earnings Date

Feb 08, 2024

Earnings per share (EPS)3.80
Gross Margin89.17%
Net Profit Margin13.10%
Debt/Equity Ratio76.8%

How did AZN perform over the long term?

See historical performance and comparison

Dividends

2.2%

Current Dividend Yield

76%

Payout Ratio